Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience

References

• Dorfman HD, Czerniak B. Bone cancers. Cancer 1995; 75: 203–10
   PubMed Web of Science ®Google Scholar
• Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma. DNA Cell Biol 2007; 26: 1–18
   PubMed Web of Science ®Google Scholar
• Malawer, MM, Helman, LJ, O'Sullivan, B. Sarcomas of bone. VT Devita, Hellman, S, Rosenberg, SA. Cancer: Principles and practice of oncology, 7th ed. Philadelphia: Lippincott-Raven publishers; 2005; 1638–86.
   Google Scholar
• Giuliano AE, Feig S, Eilber FR. Changing metastatic patterns of osteosarcoma. Cancer 1984; 54: 2160–4
   PubMed Web of Science ®Google Scholar
• Jeffree GM, Price CH, Sissons HA. The metastatic patterns of osteosarcoma. Br J Cancer 1975; 32: 87–107
   PubMed Web of Science ®Google Scholar
• Kayton ML, Huvos AG, Casher J, Abramson SJ, Rosen NS, Wexler LH, et al. Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma. J Pediatr Surg 2006; 41: 200–6
   PubMedGoogle Scholar
• Aung L, Gorlick R, Healey JH, Shi W, Thaler HT, Shorter NA, et al. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. J Clin Oncol 2003; 21: 342–8
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Higgins IT. Bone metastasis in osteogenic sarcoma. Arch Intern Med 1966; 118: 203–4
   PubMed Web of Science ®Google Scholar
• Currall VA, Dixon JH. Synchronous multifocal osteosarcoma: Case report and literature review. Sarcoma 2006; 3 Pages, Article ID 53901
   Google Scholar
• Rodriguez EK, Hornicek FJ, Gebhardt MC, Mankin HJ. Metachronous osteosarcoma: A report of five cases. Clin Orthop Relat Res 2003; 411: 227–35
   Google Scholar
• Unni, KK. Dahlin′s bone tumors. General aspects and data on 11.807 cases, 5th ed. PhiladelphiaPennsylvania: Lippincott Williams & Wilkins; 1996.
   Google Scholar
• Jaffe N, Pearson P, Yasko AW, Lin P, Herzog C, Raymond K. Single and multiple metachronous osteosarcoma tumors after therapy. Cancer 2003; 98: 2457–66
   PubMed Web of Science ®Google Scholar
• Bacci G, Fabbri N, Balladelli A, Forni C, Palmerini E, Picci P. Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients. J Bone Joint Surg Br 2006; 88: 1071–5
   PubMedGoogle Scholar
• Fitzgerald RH, Jr, Dahlin DC, Sim FH. Multiple metachronous osteogenic sarcoma. Report of twelve cases with two long-term survivors. J Bone Joint Surg Am 1973; 55: 595–605
   PubMed Web of Science ®Google Scholar
• Bruland OS, Hoifodt H, Saeter G, Smeland S, Fodstad O. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res 2005; 11: 4666–73
   PubMed Web of Science ®Google Scholar
• Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 1997; 33: 1725–31
   PubMed Web of Science ®Google Scholar
• Aksnes LH, Hall KS, Folleraas G, Stenwig AE, Bjerkehagen B, Taksdal I, et al. Management of high-grade bone sarcomas over two decades: The Norwegian Radium Hospital experience. Acta Oncol 2006; 45: 38–46
   PubMed Web of Science ®Google Scholar
• Fletcher, CDM, Unni, KK, Mertens, F. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002.
   Google Scholar
• Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol 2000; 1: 258–61
   PubMedGoogle Scholar
• Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221–30
   PubMed Web of Science ®Google Scholar
• Saeter G, Alvegard TA, Elomaa I, Stenwig AE, Holmstrom T, Solheim OP. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group study. J Clin Oncol 1991; 9: 1766–75
   PubMed Web of Science ®Google Scholar
• Smeland S, Muller C, Alvegaard TA, Wiklund T, Wiebe T, Bjork O, et al. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: Prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39: 488–94
   PubMed Web of Science ®Google Scholar
• Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, et al. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005; 23: 8845–52
   PubMed Web of Science ®Google Scholar
• Brach del Prever A, Smeland S, Tienghi A, Hall KS, Aglietta M, Bernini G, et al. High-risk osteosarcoma (OS): Preliminary results of the ISG-SSG II protocol. J Clin Oncol 2005 ASCO annual meeting proceedings 2005; 23(16S)9002
   Google Scholar
• Carrle D, Bielack SS. Current strategies of chemotherapy in osteosarcoma. Int Orthop 2006; 30: 445–51
   PubMed Web of Science ®Google Scholar
• Amstutz HC. Multiple osteogenic sarcomata–metastatic or multicentric? Report of two cases and review of literature. Cancer 1969; 24: 923–31
   PubMed Web of Science ®Google Scholar
• Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: Osteosarcoma and related tumors. Cancer Genet Cytogenet 2003; 145: 1–30
   PubMed Web of Science ®Google Scholar